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Background: Moderate to severe renal insufficiency and albuminuria have been shown to be independent risk factors
for atherosclerosis. However, little is known about the direct association between subclinical atherosclerosis evaluated
by carotid artery intima-media thickness (IMT) and microalbuminuria in elderly patients with normal renal function.
Methods: Subjects were 272 elderly patients (age ≥ 60 years) with normoalbuminuria (n= 238) and microalbuminuria
(n= 34). Carotid IMT was measured by means of high-resolution B-mode ultrasonography. Estimated glomerular
filtration rate (eGFR)≥ 60 ml/min/1.73 m2 was defined as normal renal function. Those who had macroalbuminuria and
atherosclerotic vascular disease were not included.
Results: Compared to subjects with normoalbuminuria, subjects with microalbuminuria had higher mean carotid IMT
(1.02 ± 0.38 vs. 0.85 ± 0.28 mm; P< 0.01) and maximal IMT (1.86 ± 0.86 vs. 1.60 ± 0.73 mm; P= 0.06). By a multiple linear
regression, microalbuminuria positively correlated with mean carotid IMT after adjusting for traditional cardiovascular
disease risk factors including age, sex, hypertension, diabetes, smoking, total cholesterol, pulse pressure, waist
circumference, serum uric acid. As a categorical outcome, the prevalence of the highest mean cariotid IMT quartile
(increased IMT≥ 1.05 mm) was compared with the lower three quartiles. After adjusted for potential confounders,
microalbuminuria was associated with increased carotid IMT, with an odds ratio of 2.95 [95 % confidence interval, 1.22
– 7.10]. eGFR was not significantly associated with mean carotid IMT in our analysis.
Conclusions: A slight elevation of albuminuria is a significant determinant of carotid IMT independent of traditional
cardiovascular risk factors in our patients. Our study further confirms the importance of intensive examinations for the
early detection of atherosclerosis when microalbuminuria is found in elderly patients, although with normal renal function.
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Cardiovascular disease (CVD) is the main cause of mor-
tality and morbidity in western and developing countries
[1-3]. CVD rates are substantially higher among elderly
people than the general population. An increased num-
ber of elderly patients with CVD present a large social
problem. Methods for screening the risk of CVD is one* Correspondence: xudongmei63@163.com
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reproduction in any medium, provided the orfundamental strategy for the primary prevention of CVD,
but the highest risk patients should be identified to
maximize the benefit/cost ratio of treatments[4]. Renal
dysfunction and albuminuria could be as new cardiovas-
cular risk factors or markers that may improve risk pre-
diction and help to identify the highest-risk patients. A
decreased estimated glomerular filtration rate (eGFR) is a
risk factor of CVD[5,6] and is associated with cardiovas-
cular mortality and morbidity in both high-risk patients
[7,8] and the general population[9]. Microalbuminuria as
well as macroalbuminuria are important markers for thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kong et al. BMC Nephrology 2012, 13:37 Page 2 of 7
http://www.biomedcentral.com/1471-2369/13/37progression of renal dysfunction and are currently recog-
nized as predictive factors for CVD[10-12]. Carotid ar-
tery intima-media thickness (IMT) have been proposed
as a quantitative index of subclinical atherosclerosis in
monitoring disease progression and as surrogate mea-
sures for CVD[13,14]. Increased IMT is correlated with
atherosclerotic vascular disease, such as coronary artery
disease and stroke[15], and predicts future vascular
events after other conventional vascular risk factors that
have been adjusted in the general population [16-18].
To our knowledge, little is known about the direct as-
sociation between subclinical atherosclerosis evaluated
by carotid artery intima-media thickness (IMT) and
microalbuminuria in elderly patients with normal renal
function. We performed this cross-sectional study to de-
scribe the relationship between microalbuminuria and
carotid IMT.Methods
Study population
The subjects were 272 elderly patients who visited the
Health Checkup Clinic consecutively and fulfilled the fol-
lowing criteria: (I) age ≥ 60 years, (II) no manifest con-
comitant atherosclerotic vascular disease (myocardial
infarction, stroke and peripheral arterial disease), (III) no
macroalbuminuria defined as albumin-to-creatinine
(ACR)≥ 300 mg/g creatinine, (IV) eGFR ≥ 60 ml/min/
1.73 m2, and (V) no history of carotid artery surgery. The
investigation started in May 2008 and ended in October
2009. The ethics committee in Qianfoshan Hospital
approved the study. All participants gave written
informed consent prior to data collection.Blood biochemistry measurements and biometric
parameters
Blood was collected by means of venipuncture after an
overnight fast of at least 10 hours. Serum creatinine was
measured by means of the using the Roche enzymatic
method on an automatic biochemistry analyzer (Roche P
Modular with Roche Creatininase Plus assy, Hoffman-La
Roche, Ltd., www.roche.com). eGFR was calculated using
the Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation[19]. Morning sport urine samples
were collected to detect albumin and creatinine. Urinary
albumin was measured using immunoturbidimetric
methods (Automatic protein analyzer, Siemens medical
diagnostic products, Shanghai). Urinary albumin-
creatinine ratio (ACR, in milligrams per gram) was calcu-
lated. Albuminuria were defined as the presence of ACR
> 17 mg/g for males and> 25 mg/g for females[5].
Macroalbuminuria was defined as ACR≥ 300 mg/g. Fast-
ing blood glucose, serum total cholesterol, low-density
lipoprotein cholesterol, and high-density lipoprotein(HDL) cholesterol, triglycerides, and serum uric acid
were also measured by automatic biochemistry analyzer.
Sociodemographic characteristics, health history (eg,
hypertension and diabetes), and lifestyle behavior (eg,
smoking) were obtained by means of questionnaire. The
body mass index (BMI) was calculated as weight (in kilo-
grams) divided by height squared (in square meters).
Waist circumference was measured at the narrowest
point between greater trochanter and costal margin. The
blood pressure was measured according to the guidelines
presented in the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure[20]. Hypertension
was defined by the finding on three consecutive measure-
ments at the clinic obtained two weeks apart of a mean
systolic blood pressure of more than 140 mm Hg or a
mean diastolic blood pressure of more than 90 mm Hg,
or both, or patients already being priscribed by antihy-
pertensive medicaments. Diabetes was defined as fasting
blood glucose≥ 7.0 mmol/L or by the use of hypoglycemic
agents or by self-reported history of diabetes.
Determination of carotid IMT
Carotid artery IMT was assessed in the B-mode presenta-
tion using ALOKA prosound α10 ultrasound machine as
described by Zhang L et al.[21] using a transducer fre-
quency of 4 to 13 MHz. IMT is defined as the distance
from the leading edge of the first echogenic line to that of
the second. The first line represents the lumen-intima
interface, and the second line represents the collagen-
containing upper layer of the adventitia. The carotid
artery was scanned bilaterally in longitudinal and trans-
verse planes. Far-wall carotid IMT was visualized bilat-
erally at 3 sites: the common carotid artery (20 mm
proximal from the flow divider), carotid bulb, and internal
carotid artery (10 mm distal from the flow divider). Two
measurements were obtained for each site at 5-mm inter-
vals during systole of a single heartbeat for off-line meas-
urement. The mean of six readings was calculated as
mean IMT, and maximal carotid IMT was defined as max-
imal IMT of six readings. All scans and measurements
were performed by the same observer. The correlation co-
efficient for intraobserver was 0.954 (P< 0.001), and the
mean difference for intraobserver was 0.04 mm. The dis-
tribution of observed IMT was right skew. The upper
quartile of IMT was used as a categorical dependent vari-
able for analyses, in comparison with the lower three
quartiles. In the absence of evidence about whether a loga-
rithmically or other transformed IMT measurement was a
valid indicator of risk, we adopted the categorical ap-
proach. We chose to separate the highest quartile because
the IMT measurements in this quartile were substantially
higher than the lower three quartiles. The highest mean
IMT quartile (≥ 1.05 mm) was termed ‘increased IMT’.
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tiles, in contrast, were tightly bunched over a limited
range, and these quartiles were combined for analysis.
Statistical analysis
Data were presented as proportions for categorical
variables and mean ± SD or median [interquartile range
(IQR)] for continuous variables. Comparisons between
those with and without increased IMT were made
using t-test or Wilcoxon rank-sum test for continuous
variables and chi-square statistics for categorical vari-
ables. Mean and maximal IMT also were compared
using t-test analysis of variance based on eGFR and
microalbuminuria.
Multiple linear regression were performed to assess
the combined effects of clinical variables on mean
IMT. Independent variables included age, sex, smok-
ing, diabetes, hypertension, serum uric acid, total chol-
esterol, triglycerides, HDL cholesterol, pulse pressure,Table 1 Demographic and clinical characteristics of the study
All (n = 272) < 1.05
Age (y) 70.2 ± 3.9 69.8 ± 3
Male (%) 52.6 46.4
Current smoker (%) 33.8 29.7
Hypertension (%) 82.7 82.8
Diabetes (%) 37.9 36.4
SBP (mmHg) 138.2 ± 17.7 136.9 ±
DBP (mmHg) 77.7 ± 10.3 77.6 ± 9
PP (mmHg) 60.5 ± 14.1 59.3 ± 1
BMI (kg/m2) 24.0 ± 2.5 24.4 ± 2
Waist circumference (cm) 89.5 ± 9.2 88.8 ± 9
Central obesity (%) 67.5 68.3
Total cholesterol (mmol/L) 5.17 ± 0.99 5.18 ± 1
Triglycerides(mmol/L) 1.99 ± 1.41 1.93 ± 1
HDL cholesterol (mmol/L) 1.36 ± 0.34 1.40 ± 0
Hypercholesterolemia (%) 13.2 13.9
Hypertriglyceridemia (%) 49.6 48.3
Serum creatinine (mg/dL) 0.70 ± 0.13 0.69 ± 0
eGFR (ml/min/1.73 m2) 91.1 ± 8.5 91.3 ± 8
Serum uric acid (μmol/L) 305.3 ± 74.4 302.4 ±
ACR (median,IQR) 3.1 (1.8-8.0) 3.1 (1.8
Microalbuminuria (%) 12.5 9.6
Mean IMT (mm) 0.87 ± 0.30 0.74 ± 0
Maximal IMT (mm) 1.64 ± 0.75 1.35 ± 0
Note: To convert serum cholesterol in mmol/L to mg/dL, multiply by 38.67; serum t
to μmol/L, multiply by 88.4; serum uric acid in μmol/L to mg/dL, multiply by 0.0168
men or greater than 80 cm for women; Hypercholesterolemia was defined as total
triglycerides greater than 150 mg/dL.
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse
glomerular filtration rate; ACR, albumin-creatinine ratio; IQR, interquartile range; IMTmicroalbuminuria, eGFR and waist circumference. The
association between microalbuminuria and increased
IMT was analyzed using Logistic regression models.
Age- and Sex-adjusted adds ratios (ORs) with 95 %
confidence interval (CI) were reported. We then used
forward selection method to build a parsimonious
model to adjust for other confounders. Covariates
under consideration include age (continuous), sex (fe-
male vs. male), current smoking (yes/no), hypertension
(yes/no), diabetes (yes/no), pulse pressure (continuous),
total cholesterol (continuous), HDL cholesterol (con-
tinuous) and eGFR (continuous). We forced age and
gender into the model. For covariates that did not
enter the model, we then added them to the model in-
dividually. If the OR of microalbuminuria changed> 20
%, we then kept it in the final model.
All analyses were performed by SPSS statistical pack-
age, version 16.0 (SPSS, Inc., Chicago, IL). A P value of
less than 0.05 is considered statistically significant.population based on the increased mean IMT
mm (n=209) ≥ 1.05 mm (n= 63) P value





17.9 142.6 ± 16.6 0.03
.9 78.2 ± 11.4 0.68
4.3 64.4 ± 12.7 0.01
.5 22.9 ± 2.3 < 0.001
.3 91.5 ± 8.7 0.04
65.1 0.65
.00 5.15 ± 0.95 0.88
.20 2.18 ± 1.96 0.21
.35 1.24 ± 0.27 < 0.01
11.1 0.68
54.0 0.47
.13 0.74 ± 0.14 0.03
.7 90.4 ± 7.8 0.48
74.5 314.8 ± 73.3 0.25
-7.1) 3.0 (1.5-15.2) 0.46
22.2 0.02
.15 1.33 ± 0.22 < 0.001
.54 2.60 ± 0.53 < 0.001
riglycerides in mmol/L to mg/dL, multiply by 88.545; serum creatinine in mg/dL
1. Central obesity was defined as a waist measurement greater than 90 cm for
cholesterol greater than 240 mg/dL; Hypertriglyceridemia was defined as
pressure; BMI, body mass index; HDL, high-desity lipoprotein; eGFR, estimated
, intima-media thickness.
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General characteristics of all patients are shown in
Table 1. The mean age of 272 subjects was 70.2 years
(range, 61-83 years), and 52.6 % were male. Mean eGFR
was 91.9 ml/min/1.73 m2 (range, 63.6-118.9 ml/min/
1.73 m2). Patients with increased IMT were older and
more likely to be male, current smoking and having
microalbuminuria. They were more likely to have higher
systolic blood pressure, pulse pressure, waist circumfer-
ence and lower BMI and HDL cholesterol. The percen-
tages of hypertension and diabetes were not statistically
different in patients with non-increased IMT compared
with those with increased IMT, which was 82.8 % vs.
82.5 % (P= 1.0) and 36.4 % vs. 42.9 % (P= 0.38),
respectively.
Compared to subjects with normoalbuminuria (n= 238),
subjects with microalbuminuria (n= 34) had higher mean
IMT (1.02 ± 0.38 vs. 0.85± 0.28 mm; P< 0.01) and max-
imal IMT (1.86 ± 0.86 vs. 1.60± 0.73 mm; P=0.06). Simi-
lary, compared to patients with eGFR ≥ 90 ml/min/
1.73 m2 (n =164), patients with eGFR ranged from 60 to
89 ml/min/1.73 m2 tended to have greater maximal IMT
(1.76± 0.75 vs. 1.55± 0.75 mm, P= 0.03). However, the
mean IMT was not statistically different in eGFR ranged
from 60 to 89 ml/min/1.73 m2 and eGFR ≥ 90 ml/min/
1.73 m2 groups (0.90 ± 0.29 vs. 0.86± 0.31 mm, P= 0.31).
In a univariable linear regression, microalbuminuria
positively correlated with mean IMT (β= 0.173 ± 0.055,
P< 0.01). After adjusting for age, sex, hypertension,
diabetes, smoking, total cholesterol, triglycerides, HDL





Sex (1 =male, 2 = female) −0.116
Current smoker (1 = yes, 0 = no) 0.147
Diabetes (1 = yes, 0 = no) 0.044
Hypertension (1 = yes, 0 = no) −0.010
Serum uric acid (μmol/L) < 0.001
Total cholesterol (mmol/L) 0.060
Triglycerides (mmol/L) < 0.0001
HDL cholesterol (mmol/L) −0.213
PP (mmHg) 0.004
Microalbuminuria (%) (1 = yes, 0 = no) 0.134
eGFR (ml/min/1.73 m2) < 0.001
Waist circumference (cm) < 0.001
Note: To convert serum cholesterol in mmol/L to mg/dL, multiply by 38.67; serum t
to mg/dL, multiply by 0.01681.
Abbreviations: HDL, high-desity lipoprotein; PP, pulse pressure; eGFR, estimated gloserum uric acid, microalbuminuria was still independ-
ently associated with mean IMT (β= 0.134 ± 0.052,
P = 0.01) (Table 2).
In primary analysis, microalbuminuria was associated
with increased IMT after adjusting for age and sex, with
an OR of 3.38 (95 % CI, 1.50 - 7.60). The association was
also statistically significant in the fully adjusted model,
with an OR of 2.95 (95 % CI, 1.22-7.10) (Table 3).
Discussion
Our results showed that subclinical atherosclerosis eval-
uated by carotid IMT increased significantly in subjects
with microalbuminuria in elderly patients. Microalbumi-
nuria was positively correlated with increased IMT after
adjusting for traditional cardiovascular disease risk fac-
tors, whereas eGFR was not independently associated
with increased IMT.
Carotid artery IMT have been proposed as a quantita-
tive index of subclinical atherosclerosis in monitoring
disease progression and as surrogate measures for CVD
[13,14]. Epidemiological studies showed that increases in
carotid IMT were associated with risk of CVD[15], and
predicts future vascular events in the general population
[16-18].
Previous studies showed an association between eGFR
and atherosclerosis[22-25]. Lisowska et al.[25] found a sig-
nificant negative correlation between eGFR with the IMT
in patients with coronary artery disease. Preston et al.[26]
found patients with stages 3 to 4 renal function had
increased carotid IMT compared with healthy normoten-






0.043 −0.192 < 0.01
0.040 0.230 < 0.001
0.036 0.070 0.22
0.048 −0.012 0.84
< 0.001 −0.031 0.63
0.025 0.195 0.02
0.015 <0.001 1.00





riglycerides in mmol/L to mg/dL, multiply by 88.545; serum uric acid in μmol/L
merular filtration rate.; IMT, intima-media thickness.
Table 3 Multivariate Logistic regression analysis for
increased mean IMT with different variables
Variables Age- and Sex-adjusted
ORa (95 % CI)
Multivariable
adjusted
ORb (95 % CI)
Age (continuous) 1.08 (1.00-1.16) 1.09 (1.01-1.19)
Sex (female vs. male) 0.34 (0.18-0.63) 0.32 (0.14-0.71)
Current smoking (yes vs. no) 1.47 (0.77-2.82) 1.73 (0.86-3.49)
Hypertension (yes vs. no) 1.13 (0.52-2.45) 0.55 (0.22-1.38)
Diabetes (yes vs. no) 1.45 (0.80-2.64) 1.11 (0.57-2.12)
PP (continuous) 1.03 (1.00-1.05) 1.03 (1.01-1.06)
Microalbuminuria (yes vs. no) 3.38 (1.50-7.60) 2.95 (1.22-7.10)
Total cholesterol (continuous) 1.26 (0.92-1.73) 1.89 (1.26-2.85)
HDL cholesterol (continuous) 0.29 (0.11-0.79) 0.11 (0.03-0.38)
eGFR (continuous) 0.99 (0.96-1.02) 0.99 (0.96-1.03)
Abbreviations: PP, pulse pressure; HDL, high-desity lipoprotein; eGFR,
estimated glomerular filtration rate; IMT, intima-media thickness.
aExcept for OR of age and sex, all ORs were age and sex adjusted.
bModel was adjusted for other covariates in the table.
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for age[28] or other CVD risk factors[29]. Controversy
exists concerning whether the vascular disease associated
with decreased eGFR is caused predominantly by athero-
sclerosis associated with traditional risk factors or arterial
disease associated with such uremic factors as vascular
calcification. Mineral and bone disorder is a common
complication of chronic kidney disease, especially for end-
stage renal disease patients[30]. Gradual decline in renal
phosphorus clearance during the progression of CKD
leads to increase of serum phosphorus concentration.
Hyperphosphatemia could cause vascular calcification and
increase the incidence of cardiovascular events[31,32]. In
this study, although serum phorus levels were not tested,
we did not find a difference in eGFRs between patients
with and without increased carotid IMT. In our analysis,
factors associated with carotid IMT were predominantly
traditional atherosclerotic risk factors, whereas eGFR was
not independently associated with carotid IMT, which
indicated that increased IMT in our patients might be
caused at least by traditional risk factors. The correlations
of IMT with the traditional CVD risk markers such as age,
sex, smoking, cholesterol and pulse pressure, that we
observed were compatible with reports in other popula-
tion. These correlations support the use of IMT as a mar-
ker of CVD risk, as well as a similar role for these
traditional CVD risk factors in the elderly patients with
normal renal function.
Impairment of renal function (eGFR) can accompany
albuminuria. Recent studies demonstrated that eGFR is
associated with subclinical atherosclerosis independent
of albuminuria[33,34]. Ito H et al.[35] found that the
eGFR, but not the stage of diabetic nephropathy graded
by the urinary albumin excretion, is associated with thecarotid IMT in patients with type 2 diabetes. Other stud-
ies showed that microalbuminuria was not significantly
correlated with carotid IMT in general population after
adjusting for traditional cardiovascular disease risk fac-
tors[21,36,37]. Controversially, our results showed that
after adjusted for potential confounders, microalbumi-
nuria was associated with increased IMT, with an odds
ratio of 2.95 [95 % confidence interval, 1.22 – 7.10]. Ad-
justment for traditional CVD risk factors and eGFR,
however, this did not influence the association between
carotid IMT and microalbuminuria in the multiple linear
regression analysis.
Possible mechanisms for the relationship between
microalbuminuria and IMT remain unclear. However,
vascular endothelial damage may cause atherosclerosis
and albuminuria[38]. Endothelial dysfunction alters
endothelial properties and exerts structure and func-
tion effects on the target vessel, and may therefore
enchance inward remodeling. In addition, endothelial
dysfunction within the glomerular basement mem-
brane may modify glomerular barrier permeability,
thus leading to the excretion of albumin into the
urine [39].
This study possesses some limitations. First, this study
used a convenience sample which was not based on a
community-based screening and could introduce bias.
And our data was cross-sectional and do not provide an
insight into the mechanisms that are responsible for the
observed associations. Second, we used a single morning
sport urine sample to assess microalbuminuria, instead
of timed urine collections, which would be more prefer-
able. Third, we could not collect detailed data on the
medications that the participants received. Finally, non-
traditional risk factors of increased IMT were not
explored in the present study.
Conclusions
Our study indicates that arterial changes are initiated in
elderly patients with microalbuminuria. Traditional fac-
tors might contribute to the increased carotid IMT,
whereas the association between microalbuminuria and
increased IMT highlights the importance of evaluating
the progression of silent, asymptomatic systemic vascu-
lar disease in elderly patients, although with normal
renal function.
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